Small‐molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase‐associated malignant glioma growth
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small‐molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase‐associated malignant glioma growth
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 176, Issue 11, Pages 1680-1699
Publisher
Wiley
Online
2019-02-14
DOI
10.1111/bph.14622
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury
- (2019) Jianxiong Jiang et al. NEUROPHARMACOLOGY
- Discovery of 2-Piperidinyl Phenyl Benzamides and Trisubstituted Pyrimidines as Positive Allosteric Modulators of the Prostaglandin Receptor EP2
- (2018) Jianxiong Jiang et al. ACS Chemical Neuroscience
- Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
- (2018) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Brain Tumors: Challenges and Opportunities to Cure
- (2017) Ingo K. Mellinghoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Adult Glioblastoma
- (2017) Brian M. Alexander et al. JOURNAL OF CLINICAL ONCOLOGY
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
- (2017) Simon D Harding et al. NUCLEIC ACIDS RESEARCH
- Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype
- (2017) Xu Kang et al. Scientific Reports
- Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus
- (2016) Yifeng Du et al. Expert Review of Neurotherapeutics
- Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4
- (2016) Katharina Ochs et al. JOURNAL OF NEUROCHEMISTRY
- Cox-2-derived PGE2induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma
- (2016) Peter J. Cook et al. NEURO-ONCOLOGY
- Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus
- (2016) Yifeng Du et al. Expert Review of Neurotherapeutics
- Prostaglandin E2 plays a major role in glioma resistance and progression
- (2016) Lisa Oliver et al. Translational Cancer Research
- Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
- (2015) G O'Callaghan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Experimental design and analysis and their reporting: new guidance for publication in BJP
- (2015) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Definition of Prostaglandin E2-EP2 Signals in the Colon Tumor Microenvironment That Amplify Inflammation and Tumor Growth
- (2015) X. Ma et al. CANCER RESEARCH
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus
- (2015) Jianxiong Jiang et al. NEUROBIOLOGY OF DISEASE
- Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter
- (2015) Jian-Ge Qiu et al. Oncotarget
- Radiation-induced PGE2 sustains human glioma cells growth and survival through EGF signaling
- (2015) Emeline Brocard et al. Oncotarget
- COX-2 overexpression increases malignant potential of human glioma cells through Id1
- (2015) Kaiming Xu et al. Oncotarget
- Development of second generation EP2 antagonists with high selectivity
- (2014) Thota Ganesh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Lead Optimization Studies of Cinnamic Amide EP2 Antagonists
- (2014) Thota Ganesh et al. JOURNAL OF MEDICINAL CHEMISTRY
- The UCSC Cancer Genomics Browser: update 2015
- (2014) Mary Goldman et al. NUCLEIC ACIDS RESEARCH
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Glioblastoma and Other Malignant Gliomas
- (2013) Antonio Omuro JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation
- (2013) Jianxiong Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection
- (2013) Jianxiong Jiang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Discovery and Characterization of Carbamothioylacrylamides As EP2 Selective Antagonists
- (2013) Thota Ganesh et al. ACS Medicinal Chemistry Letters
- Interleukins in glioblastoma pathophysiology: implications for therapy
- (2012) YT Yeung et al. BRITISH JOURNAL OF PHARMACOLOGY
- Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2
- (2012) J. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2
- (2011) Xinrong Ma et al. BREAST CANCER RESEARCH AND TREATMENT
- In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist
- (2011) KJ af Forselles et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prostanoid Receptors
- (2011) Takako Hirata et al. CHEMICAL REVIEWS
- Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga
- (2010) Tilo Grosser et al. Annual Review of Medicine
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor
- (2010) J. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation